Marijn Vis

Development of antiinfliximab antibodies and relationship to clinical response in patients with rheumatoid arthritis

Marijn Vis, Willem F. Lems, Alexandre E. Voskuyl et al. · Arthritis & Rheumatism · 2006 · 469 citations

Medicine, Clinical Sciences, Internal Medicine +17

Evaluation of bone mineral density, bone metabolism, osteoprotegerin and receptor activator of the NFκB ligand serum levels during treatment with infliximab in patients with rheumatoid arthritis

Marijn Vis, Espen A Havaardsholm, Glenn Haugeberg et al. · Annals of the Rheumatic Diseases · 2006 · 245 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +17

Short term effects of infliximab on the lipid profile in patients with rheumatoid arthritis.

Marijn Vis, Michael T. Nurmohamed, Gertjan Wolbink et al. · PubMed · 2005 · 126 citations

Medicine, Pharmacology, Pharmacotherapy +17

Changes in lipid profile during infliximab and corticosteroid treatment in rheumatoid arthritis

Matthew Peters, Marijn Vis, Vokko P. van Halm et al. · Annals of the Rheumatic Diseases · 2007 · 103 citations · Full text

Medicine, Immunology, Pharmacotherapy +17

High incidence of vertebral and non-vertebral fractures in the OSTRA cohort study: a 5-year follow-up study in postmenopausal women with rheumatoid arthritis

Marijn Vis, Espen A. Haavardsholm, Pernille Bøyesen et al. · Osteoporosis International · 2011 · 77 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +15